Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 590

1.

Effects of varenicline on smoking cue–triggered neural and craving responses.

Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O'Brien CP, Childress AR.

Arch Gen Psychiatry. 2011 May;68(5):516-26. doi: 10.1001/archgenpsychiatry.2010.190. Epub 2011 Jan 3.

2.

Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.

Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL.

Arch Gen Psychiatry. 2011 May;68(5):505-15. doi: 10.1001/archgenpsychiatry.2010.193. Epub 2011 Jan 3.

3.

Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.

Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H.

Psychopharmacology (Berl). 2014 Sep;231(18):3799-807. doi: 10.1007/s00213-014-3518-1. Epub 2014 Mar 20.

4.

Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study.

Hartwell KJ, Lematty T, McRae-Clark AL, Gray KM, George MS, Brady KT.

Am J Drug Alcohol Abuse. 2013 Mar;39(2):92-8. doi: 10.3109/00952990.2012.750665.

5.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743
6.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
8.

The effects of varenicline on stress-induced and cue-induced craving for cigarettes.

Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K.

Drug Alcohol Depend. 2013 Jul 1;131(1-2):136-42. doi: 10.1016/j.drugalcdep.2012.12.015. Epub 2013 Jan 5.

PMID:
23298651
9.
10.

Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study.

Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ.

Addict Biol. 2010 Oct;15(4):491-503. doi: 10.1111/j.1369-1600.2010.00242.x. Epub 2010 Sep 14.

11.

Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.

Lesage E, Aronson SE, Sutherland MT, Ross TJ, Salmeron BJ, Stein EA.

JAMA Psychiatry. 2017 Jun 1;74(6):632-640. doi: 10.1001/jamapsychiatry.2017.0400.

PMID:
28403383
12.

[On oral medications, especially varenicline].

Kurioka N.

Nihon Rinsho. 2013 Mar;71(3):487-92. Review. Japanese.

PMID:
23631241
13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
14.
15.

Severity of dependence modulates smokers' neuronal cue reactivity and cigarette craving elicited by tobacco advertisement.

Vollstädt-Klein S, Kobiella A, Bühler M, Graf C, Fehr C, Mann K, Smolka MN.

Addict Biol. 2011 Jan;16(1):166-75. doi: 10.1111/j.1369-1600.2010.00207.x.

PMID:
20331560
16.

Varenicline effects on craving, cue reactivity, and smoking reward.

Brandon TH, Drobes DJ, Unrod M, Heckman BW, Oliver JA, Roetzheim RC, Karver SB, Small BJ.

Psychopharmacology (Berl). 2011 Nov;218(2):391-403. doi: 10.1007/s00213-011-2327-z. Epub 2011 May 11.

17.

Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.

Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C.

Biol Psychiatry. 2010 Apr 15;67(8):715-21. doi: 10.1016/j.biopsych.2010.01.016. Epub 2010 Mar 6.

PMID:
20207347
18.

Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.

Gass JC, Wray JM, Hawk LW, Mahoney MC, Tiffany ST.

Psychopharmacology (Berl). 2012 Sep;223(1):107-16. doi: 10.1007/s00213-012-2698-9. Epub 2012 Apr 4.

19.

Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study.

Attwood AS, Williams T, Adams S, McClernon FJ, Munafò MR.

Trials. 2014 Oct 7;15:391. doi: 10.1186/1745-6215-15-391.

20.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839

Supplemental Content

Support Center